DocWire News Editors

DocwireNews

Janssen, a pharmaceutical company under Johnson &amp; Johnson, has designed a virtual reality (VR) platform that is designed to train nurses. The system simulates a clinical setting in which nurses use VR tools and interface to administer medications to a virtual patient. The VR was named Most Valuable HCP Initiative at EyeforPharma’s annual awards ceremony this year in Barcelona, Spain.
The main goal of the experience is to increase nurse confidence in administering their first multiple myeloma drug treatment. Through use of the HTC Vive VR kit, nurses are immersed in a virtual chemotherapy office where they can interact with many elements, including the patient. Nurses reports after using the VR were positive, with all of the users believing the experience would assist in their daily clinical practice and recommending the VR to a colleague.
<iframe loading="lazy" src="https://www.youtube.com/embed/SGpliJ8C798" width="853" height="480" frameborder="0" allowfullscreen="allowfullscreen"></iframe>
This concept arose after Janssen’s UK early access program for a new multiple myeloma drug came about. The company determined there was a need for a detailed training system to guide National Health Service nurses through their first administration. The aspect of VR allows them to practice this procedure in a risk-free environment that accurately simulates the experience.
After receiving this award in Spain, the team behind the VR said: “Winning this award is an accumulation of a lot of different emotions. It has been a rollercoaster journey. We started with the idea to solve something, then thought: ‘How do we put these insights into practice and what’s the best modality to do it?’ We then had to deal with internal challenges; working out how to get regulatory approval for a virtual environment and how to find the right supplier. The award is a nice point of recognition of getting to the end point.”
“For us the real benefit was that patient treatment was not delayed, because the training took place before the product was launched. You build the nurses confidence — before they would delay the infusion for another week or so to get training sorted. Multiple myeloma patients have months to live so you can’t afford to delay their treatment.”
<a href="https://proddocwire.wpengine.com/future-of-medicine/vrhealth-and-oculus-form-partnership-to-integrate-virtual-reality-vr-into-healthcare/">READ MORE: VRHealth and Oculus Form Partnership to Integrate Virtual Reality (VR) into Healthcare</a>
The panel of judges, comprised of patients, patient advocates, healthcare professionals, and pharmaceutical executives, spoke very highly of the system for its ability to build nurse’s confidence prior to giving a patient their first infusion.
The launch of this system builds on Janssen’s VR experimentation in healthcare, with its SchizoLab using VR to simulate symptoms of schizophrenia to give individuals a better understanding of what living with the disease is like. Similar VR technologies have been used to <a href="https://proddocwire.wpengine.com/docwire-pick/future-of-medicine-picks/vr-simulating-dementia-makes-youth-sympathize-with-elders/">simulate dementia symptoms</a> to enlighten those unaffected as to what patients are going through. These systems allow providers to experience what the symptoms are truly like, allowing them to sympathize with their patients.
<blockquote class="twitter-tweet" data-lang="en">
Janssen’s VR nurse training for a new multiple myeloma treatment wins Most Valuable HCP Initiative. <a href="https://twitter.com/hashtag/efpBarca?src=hash&amp;ref_src=twsrc%5Etfw">#efpBarca</a>
— Dr. Pénzes János (@drpenzesjanos) <a href="https://twitter.com/drpenzesjanos/status/974221017429237760?ref_src=twsrc%5Etfw">March 15, 2018</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Sources: <a href="https://www.policymed.com/2018/11/janssen-uses-virtual-reality-to-train-nurses.html">Policy Med</a>, <a href="https://www.eyeforpharma.com/awards/2018-winner-janssen.php">EyeforPharma</a>,

Rob Dillard

Analyzing Metabolic Risk Factors and Preventative Breast Surgical Decisions of Hereditary Breast Cancer Carriers

SABCS 2024

The Combination of Tucatinib and Alpelisib Shows Efficacy in Patients with HER2-positive Metastatic Breast Cancer

Laura Litwin

How Socioeconomic Deprivation Affects Health Care, Surgical Outcomes for US Veterans With NSCLC

Non-Small Cell Lung Cancer

Latest News

Janssen Uses VR to Train Nurses in Giving First Cancer Treatment

Future of Medicine

Janssen, a pharmaceutical company under Johnson &amp; Johnson, has designed a virtual reality (VR) platform that is designed to train nurses. The system simulates a clinical ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe